|
Marketable Securities (Details Narrative) (USD $)
|
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
| Net loss | $ (99,000)us-gaap_NetIncomeLoss | $ (3,887,000)us-gaap_NetIncomeLoss |
| Fair value | ||
| MusclePharm, Inc. [Member] | ||
| Common Stock |
260,000us-gaap_CommonStockOtherSharesOutstanding / us-gaap_SecuritiesFinancingTransactionAxis = cocp_MusclePharmIncMember |
|
| Net loss |
584,000us-gaap_NetIncomeLoss / us-gaap_SecuritiesFinancingTransactionAxis = cocp_MusclePharmIncMember |
|
| Fair value |
$ 1,975,000us-gaap_FairValueOfAssetsAcquired / us-gaap_SecuritiesFinancingTransactionAxis = cocp_MusclePharmIncMember |
|
| X | ||||||||||
|
- Definition
Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized. No definition available.
|
| X | ||||||||||
|
- Definition
The fair value of assets acquired in noncash investing or financing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|